Lv4
490 积分 2022-07-07 加入
Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response
4小时前
已完结
Interleukin-2 and interleukin-15: immunotherapy for cancer
6天前
已完结
IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction
7天前
已完结
CD56 on immune and tumor cells: what is known and beyond?
13天前
已完结
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma
14天前
已完结
Realizing the potential of agonistic antibody immunotherapy
16天前
已完结
Targeting claudins in cancer
16天前
已完结
Biologic degraders push forward in the clinic
26天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
27天前
已完结
New payloads drive next-gen antibody–drug conjugates
28天前
已完结
皖公网安备34019202002308
